Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Systematic Kaposi-Sarcoma Herpesvirus (KSHV) genome analysis from a South African HIV- and KSHV-positive patient cohort

Kaposi sarcoma herpesvirus (KSHV) is an oncogenic virus and the etiological agent of Kaposi's sarcoma, the most common AIDS-associated cancer. KSHV infection occurs primarily in Sub-Saharan Africa (SSA) where it is also associated with other pathologies such as Multicentric Castleman's Disease, Prim...

Full description

Saved in:
Bibliographic Details
Main Author: Thomas, Melissa
Other Authors: Schafer, Georgia
Format: Thesis
Language:English
English
Published: Division of Medical Biochemistry 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613211405058048
access_status_str Open Access
author Thomas, Melissa
author2 Schafer, Georgia
author_browse Schafer, Georgia
Thomas, Melissa
author_facet Schafer, Georgia
Thomas, Melissa
author_sort Thomas, Melissa
collection Thesis
description Kaposi sarcoma herpesvirus (KSHV) is an oncogenic virus and the etiological agent of Kaposi's sarcoma, the most common AIDS-associated cancer. KSHV infection occurs primarily in Sub-Saharan Africa (SSA) where it is also associated with other pathologies such as Multicentric Castleman's Disease, Primary Effusion Lymphoma and KSHV-associated inflammatory cytokine syndrome, which also occur primarily with HIV co-infection. IN SSA most individuals ac-quire KSHV infection during childhood where it remains undetected until later in life when the burden of HIV takes its effect on the immune system. There are 6 predominant KSHV subtypes world-wide, namely A, B, C, D, E and F which are determined by the highly variable K1 region of the KSHV genome. Sequencing and characterizing the circulating subtypes in a specific geographical region assist in tracking evolutionary changes as well as malignant outcomes associated with different subtypes. The aim of this study was to determine the circulating KSHV subtypes in the Western Cape region of South Africa. A total of 57 DNA samples isolated from peripheral blood of confirmed HIV/KSHV co-infected patients were selected according to KSHV viral load (VL) (> 5 copies/10 μL) and volume (> 5 μL). Of these, 20 were successfully Sanger sequenced to determine K1 subtype. Additionally, 9 samples met the criteria for whole-genome sequencing using Next Generation Sequencing (NGS). This study produced 29 K1 sequences (20 via Sanger and 9 via NGS) of which 26 were of the A subtype, specifically A5, and the remaining 3 were of the B subtype, namely B2. These results are consistent with previous studies from the same region where a trend of high A5 and B subtypes in AIDS-KS patients were reported. ORF-K15 is another variable and lytic gene associated with KSHV subtyping (alleles M, N and P). Sequencing results of the K15 gene, revealed two P subtypes, three M subtypes and four N subtypes in our samples. These novel results from the Western Cape of South Africa point towards an interesting distribution of subtypes contributing to previous reports of K15 P and M subtypes being the most prevalent in Africa. There are limited whole-genome sequences available for South Africa, therefore these sequences provide a significant contribution to the pool of sequences available for this region.
format Thesis
id oai:open.uct.ac.za:11427/41382
institution University of Cape Town (South Africa)
language English
eng
last_indexed 2026-06-10T12:32:31.718Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository
publishDate 2025
publishDateRange 2025
publishDateSort 2025
publisher Division of Medical Biochemistry
publisherStr Division of Medical Biochemistry
record_format dspace
source_str UCTD — University of Cape Town Open Access Repository
spelling oai:open.uct.ac.za:11427/41382 Systematic Kaposi-Sarcoma Herpesvirus (KSHV) genome analysis from a South African HIV- and KSHV-positive patient cohort Thomas, Melissa Schafer, Georgia Medicine Kaposi sarcoma herpesvirus (KSHV) is an oncogenic virus and the etiological agent of Kaposi's sarcoma, the most common AIDS-associated cancer. KSHV infection occurs primarily in Sub-Saharan Africa (SSA) where it is also associated with other pathologies such as Multicentric Castleman's Disease, Primary Effusion Lymphoma and KSHV-associated inflammatory cytokine syndrome, which also occur primarily with HIV co-infection. IN SSA most individuals ac-quire KSHV infection during childhood where it remains undetected until later in life when the burden of HIV takes its effect on the immune system. There are 6 predominant KSHV subtypes world-wide, namely A, B, C, D, E and F which are determined by the highly variable K1 region of the KSHV genome. Sequencing and characterizing the circulating subtypes in a specific geographical region assist in tracking evolutionary changes as well as malignant outcomes associated with different subtypes. The aim of this study was to determine the circulating KSHV subtypes in the Western Cape region of South Africa. A total of 57 DNA samples isolated from peripheral blood of confirmed HIV/KSHV co-infected patients were selected according to KSHV viral load (VL) (> 5 copies/10 μL) and volume (> 5 μL). Of these, 20 were successfully Sanger sequenced to determine K1 subtype. Additionally, 9 samples met the criteria for whole-genome sequencing using Next Generation Sequencing (NGS). This study produced 29 K1 sequences (20 via Sanger and 9 via NGS) of which 26 were of the A subtype, specifically A5, and the remaining 3 were of the B subtype, namely B2. These results are consistent with previous studies from the same region where a trend of high A5 and B subtypes in AIDS-KS patients were reported. ORF-K15 is another variable and lytic gene associated with KSHV subtyping (alleles M, N and P). Sequencing results of the K15 gene, revealed two P subtypes, three M subtypes and four N subtypes in our samples. These novel results from the Western Cape of South Africa point towards an interesting distribution of subtypes contributing to previous reports of K15 P and M subtypes being the most prevalent in Africa. There are limited whole-genome sequences available for South Africa, therefore these sequences provide a significant contribution to the pool of sequences available for this region. 2025-04-10T09:54:26Z 2025-04-10T09:54:26Z 2024 2025-04-09T09:55:51Z Thesis / Dissertation Masters MSc http://hdl.handle.net/11427/41382 en eng application/pdf Division of Medical Biochemistry Faculty of Health Sciences University of Cape Town
spellingShingle Medicine
Thomas, Melissa
Systematic Kaposi-Sarcoma Herpesvirus (KSHV) genome analysis from a South African HIV- and KSHV-positive patient cohort
thesis_degree_str Master's
title Systematic Kaposi-Sarcoma Herpesvirus (KSHV) genome analysis from a South African HIV- and KSHV-positive patient cohort
title_full Systematic Kaposi-Sarcoma Herpesvirus (KSHV) genome analysis from a South African HIV- and KSHV-positive patient cohort
title_fullStr Systematic Kaposi-Sarcoma Herpesvirus (KSHV) genome analysis from a South African HIV- and KSHV-positive patient cohort
title_full_unstemmed Systematic Kaposi-Sarcoma Herpesvirus (KSHV) genome analysis from a South African HIV- and KSHV-positive patient cohort
title_short Systematic Kaposi-Sarcoma Herpesvirus (KSHV) genome analysis from a South African HIV- and KSHV-positive patient cohort
title_sort systematic kaposi sarcoma herpesvirus kshv genome analysis from a south african hiv and kshv positive patient cohort
topic Medicine
url http://hdl.handle.net/11427/41382
work_keys_str_mv AT thomasmelissa systematickaposisarcomaherpesviruskshvgenomeanalysisfromasouthafricanhivandkshvpositivepatientcohort